Glyburide use has been approved in pregnancy; however, studies have shown some elevated risk of neonatal hypoglycemia compared to insulin, and increased expression of GLUT1 on the placenta which may facilitate higher nutrient transfer to the fetus and confer higher risk of macrosomia [73,74]. This evidence concerns the gene INS and Hypoglycemia.